Ukraine response

June 01, 2022

Novartis resumes business in Ukraine

Learn More

 

More Statements


AAA scientists in a lab in Italy

Novartis Financial Results – Q1 2022

Novartis announced the company’s financial results for the first quarter of 2022.

 

Novartis Gene Therapies Global Managed Access Program

Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.

Read More